These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11722405)

  • 1. Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia.
    Kollia P; Stavroyianni N; Stamatopoulos K; Zoi K; Viniou N; Mantzourani M; Noguchi CT; Paterakis G; Abazis D; Pangalos C; Loukopoulos D; Yataganas X
    Br J Haematol; 2001 Oct; 115(1):19-24. PubMed ID: 11722405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia.
    Kollia P; Samara M; Stamatopoulos K; Belessi C; Stavroyianni N; Tsompanakou A; Athanasiadou A; Vamvakopoulos N; Laoutaris N; Anagnostopoulos A; Fassas A
    Leuk Res; 2003 Dec; 27(12):1101-3. PubMed ID: 12921947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
    Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
    Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
    Ul-Haq R; Chitambar CR
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transferrin receptor mRNA expression. Distinct regulatory features in erythroid cells.
    Chan RY; Seiser C; Schulman HM; Kühn LC; Ponka P
    Eur J Biochem; 1994 Mar; 220(3):683-92. PubMed ID: 8143723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells.
    Morishita Y; Kataoka T; Towatari M; Ito T; Inoue H; Ogura M; Morishima Y; Saito H
    Cancer Res; 1990 Dec; 50(24):7955-61. PubMed ID: 1701357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
    de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
    Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of differential transferrin receptor expression in normal hematopoiesis.
    Sposi NM; Cianetti L; Tritarelli E; Pelosi E; Militi S; Barberi T; Gabbianelli M; Saulle E; Kühn L; Peschle C; Testa U
    Eur J Biochem; 2000 Dec; 267(23):6762-74. PubMed ID: 11082186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver reperfusion.
    Tacchini L; Fusar Poli D; Bernelli-Zazzera A; Cairo G
    Hepatology; 2002 Jul; 36(1):103-11. PubMed ID: 12085354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
    Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
    Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro.
    Li GJ; Zhao Q; Zheng W
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):188-200. PubMed ID: 15893546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dihydroartemisinin down-regulates the expression of transferrin receptor in myeloid leukemia cells].
    Wang Z; Zhou HJ
    Yao Xue Xue Bao; 2008 Jun; 43(6):576-83. PubMed ID: 18822958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction.
    Sakhinia E; Farahangpour M; Tholouli E; Liu Yin JA; Hoyland JA; Byers RJ
    J Clin Pathol; 2006 Oct; 59(10):1059-65. PubMed ID: 16644881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats.
    Han J; Day JR; Connor JR; Beard JL
    Nutr Neurosci; 2003 Feb; 6(1):1-10. PubMed ID: 12608731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
    Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
    Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transferrin function and expression: review and update.
    Lok CN; Loh TT
    Biol Signals Recept; 1998; 7(3):157-78. PubMed ID: 9672759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia.
    Garg M; Moore H; Tobal K; Liu Yin JA
    Br J Haematol; 2003 Oct; 123(1):49-59. PubMed ID: 14510942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.